Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
214.50
-1.60 (-0.74%)
At close: Mar 5, 2026
-1.11%
Market Cap 190.14B
Revenue (ttm) 81.95B
Net Income (ttm) 25.95B
Shares Out 886.45M
EPS (ttm) 29.27
PE Ratio 7.33
Forward PE 6.65
Dividend 12.00 (5.59%)
Ex-Dividend Date Nov 17, 2025
Volume 334,034
Average Volume 856,869
Open 216.10
Previous Close 216.10
Day's Range 213.90 - 216.10
52-Week Range 198.00 - 236.00
Beta 0.05
RSI 38.55
Earnings Date Apr 29, 2026

About DSE:SQURPHARMA

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anthelmintics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 15,937
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SQURPHARMA
Full Company Profile

Financial Performance

In fiscal year 2025, DSE:SQURPHARMA's revenue was 76.29 billion, an increase of 8.83% compared to the previous year's 70.10 billion. Earnings were 23.97 billion, an increase of 14.54%.

Financial Statements

News

There is no news available yet.